Appointment of Director

JPMorgan Emerging Mkts Invest Trust
16 December 2024
 

LONDON STOCK EXCHANGE ANNOUNCEMENT

 

 

JPMORGAN EMERGING MARKETS INVESTMENT TRUST PLC

 

 

APPOINTMENT OF DIRECTOR

 

 

Legal Entity Identifier: 5493001VPQDYH1SSSR77

Information disclosed in accordance with Listing Rule 9.6.11(1)

 

 

The Board of JPMorgan Emerging Markets Investment Trust plc (the "Company") is pleased to announce the appointment of Dean Buckley as a Non-Executive Director of the Company with effect from 2nd January 2025.

 

Mr. Buckley is an experienced investment professional who has held senior positions in a number of asset management firms during his career. He was Chief Executive Officer of Scottish Widows Investment Partnership and held several senior positions at HSBC Holdings plc, most recently as Chief Executive Officer of HSBC Asset Management UK & Middle East.

 

Mr. Buckley is currently the Non-Executive Chairman of Alliance Witan PLC, Fidelity Special Values PLC and Evelyn Partners Fund Solutions Limited. He is also a Non-Executive Director of Baillie Gifford & Co. Limited.

 

Previously, Mr. Buckley has held senior fund management positions at Prudential Portfolio Managers and was a Non-Executive Director of Saunderson House Limited. He was also Chair of the Audit Committee, Remuneration Committee and Senior Independent Director of JPMorgan Asia Growth & Income plc.

 

Mr. Buckley is a Fellow of the Institute of Actuaries.

 

As at the date of this announcement, Mr. Buckley was beneficially interested in 50,000 ordinary shares of the Company.

 

There is no other information to be disclosed in respect of paragraphs 9.6.13(1) - (6) of the Listing Rules in respect of Mr. Buckley.

 

16th December 2024

 

For further information, please contact:

 

 

Divya Amin

JPMorgan Funds Limited, Company Secretary

Telephone 0800 20 40 20

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings